Neuprex rBPI-21: Completed Phase III study update

Xoma Ltd. (XOMA), Berkeley, Calif. Product: Neuprex rBPI-21 Business: Infectious diseases Therapeutic category: Bacterial replication, Cytotoxic Target: Gram-negative bacterial cell membranes Descript...